Home

Alembic Pharmaceuticals Ltd 52 Week Low

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

YEARLOW

₹ 725.6

Last updated on: Apr 11, 2025

Key Highlights

  • The 52 Week Low of Alembic Pharmaceuticals Ltd is ₹ 725.6 as of 11 Apr 25 .

Company Fundamentals for Alembic Pharmaceuticals Ltd

Market Price of Alembic Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Apr 2025847.4
09 Apr 2025839.95
08 Apr 2025850
07 Apr 2025844.1
04 Apr 2025881.8
03 Apr 2025888.9
02 Apr 2025885.2
01 Apr 2025897.55
28 Mar 2025929.25
27 Mar 2025930.9

Asset Value vs Market Value of Alembic Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Alembic Pharmaceuticals Ltd News Hub

Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) f

Read more

13 Aug 24

Alembic Pharma gets US FDA nod for anticoagulant Dabigatran

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pradaxa

Read more

13 Aug 24

Alembic Pharmaceuticals Ltd leads losers in 'A' group

Steel Authority of India Ltd, IFCI Ltd, Coffee Day Enterprises Ltd and Orient Cement Ltd are among t

Read more

09 Aug 24

Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr

Revenue from operations grew 5.09% year on year (YoY) to Rs 1,561.73 crore in the quarter ended 30 J

Read more

08 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Alembic Pharmaceuticals Ltd

Why is it important to track the 52-week low of Alembic Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Alembic Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Alembic Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Alembic Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Alembic Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Alembic Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Alembic Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Alembic Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Alembic Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Alembic Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Alembic Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Alembic Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Alembic Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions